Groundbreaking Study Reveals 93% Breastfeeding Success Rate with Short-Term Donor Human Milk Supplementation!

In a remarkable breakthrough for infant nutrition, LactaLogics, a leader in human milk-based products, has unveiled compelling results from a pilot study demonstrating the effectiveness of donor human milk in enhancing breastfeeding success and promoting healthy growth in infants. These findings were recently presented at the prestigious International Society for Research in Human Milk and Lactation (ISRHML) Conference in Charleston, South Carolina, and they could redefine nutritional strategies for newborns.

The study focused on the use of pasteurized donor human milk, processed through the innovative Gentle-UHT™ method, during the vulnerable first week of a newborn’s life. The evidence collected suggests that early supplementation with donor human milk can significantly improve infant growth outcomes, facilitate the transition to exclusive breastfeeding, and prolong the duration of breastfeeding overall.

Key Insights from the Study:

An impressive 93% of infants successfully transitioned from donor human milk supplementation to exclusive breastfeeding, within just 2-7 days of age.

Infants using this supplementation experienced healthy weight recovery at risk of excessive weight loss, aligning with World Health Organization (WHO) growth standards.

Those who received supplementation earlier exhibited the most considerable increases in growth velocity, indicating a clear pattern of returning to birth weight effectively and quickly.

LactaLogics has developed a program where their BridgePacks—composed entirely of donor human milk—serve as a vital resource to mothers facing early breastfeeding challenges. One of the most significant advantages of the Gentle-UHT processing is that it allows the milk to be safely stored at room temperature, making it readily accessible for families without the need for defrosting as typical donor milk requires. This feature is particularly beneficial in the crucial early days, ensuring that infants receive the nutrition they need promptly.

Dr. Robin Hollen, a key participant in the study from Pediatric Associates, praised the initiative, stating, "The BridgePack program has shown us how accessible donor human milk can transform the early breastfeeding experience for families. It is not just about nutrition; it is about giving mothers the time and support they deserve during those challenging initial days."

Echoing these sentiments, Dr. Rebecca Perry, a neonatologist at the University of Nevada, highlighted the clinical relevance of these findings by stating, "This study showcases how critical donor human milk can be for infants, particularly those at risk of weight loss. Early and effective nutrition is essential, and this research underscores the vital role of donor milk in achieving healthy growth trajectories."

This pioneering research signals a significant advancement in breastfeeding support and infant health, advocating for further investigations into the long-term benefits of donor human milk supplementation. The study opens new avenues for improving breastfeeding rates and infant outcomes, reinforcing the essential need for continued support and education for new mothers.

For those interested in learning more about LactaLogics' innovative human milk-based products and their implications for infant nutrition, additional information is available on their website, lactalogics.com.

This is not just a study; it's a game-changer for families everywhere. What does this mean for the future of infant nutrition? Stay tuned for updates that could reshape parenting practices and healthcare protocols!